David Knighton M.D., F.A.C.S., F.A.C.A., is one of the world’s leading authorities on wound healing; a visionary medical researcher who has worked with C. Everett Koop, Judah Folkman, Thomas Hunt, and other giants in the field; and a highly successful inventor and entrepreneur. His discoveries have generated over a billion dollars in revenue, and he has put most of his own share of this revenue into further research and discovery.
For ten years, he ran the Wound Healing and Limb Salvage Clinic at the University of Minnesota Medical Center, which specialized in healing patients who had been declared unhealable by other doctors. David taught and did research at the U. of Minnesota from 1984 to 1998.
In 1984, he founded Curative Technologies, a medical technology company whose products stimulate healing in previously non-healing wounds. In the years that followed, Curative established over 200 wound healing centers around the country.
In 1991, David founded Embro Corporation, a biomedical research and development company that creates new technologies for wound healing, surgery, and treating infectious diseases. Seven years later, he founded Embro Vascular, which developed and commercialized a practical vein harvesting system.
In 1992 and 1993, he was named one of America’s top 100 doctors for his work in wound healing. In 1994, David was one of seven experts brought together by the Wound Healing Society to create formal medical definitions of wounding and healing; these definitions continue to be used throughout the world today.
David has spoken to hundreds of groups—from social workers to spiritual leaders to college students to physicians—on the topic of healing. He has published hundreds of short pieces in general-interest publications, including the Chicago Tribune, Science, the Chicago Sun-Times, and Christianity Today, as well as 100+ articles in medical journals such as Lancet, Annals of Surgery, and Cell and Tissue Research. He lives in Minneapolis with his wife Florence.
Curative Technologies, Inc.
Dr. Knighton founded CTI in 1984. Using patented technologies that resulted in growth factors being released by platelets, CTI helps people heal from wounds faster and more effectively. Beginning in the late 1980s, CTI established 115 wound care centers around the, where patients with non-healing wounds from diabetes, venous stasis, pressure sores, and other causes were treated with growth factors released from their own platelets. The company later conducted a successful initial public offering. David served as Chairman of the Board through 1989 and stayed with the company through the public offering (1991-1993).
A privately held biomedical research and development company creating technologies for vascular surgeries, wound healing, and infectious diseases. Dr. Knighton is currently Chairman and Chief Scientific Officer.
Embro Vascular, LLC
Established to commercialize a patented endoscope and method for vein removal. Embro’s technology and patents were later sold to medical device manufacturer Guidant Corporation. Dr. Knighton is currently Chairman.
Atlantic Bio Ventures, LLC
Majority owner of Creative Water Solutions, LLC. ABV commercializes natural water purification products based on sphagnum moss and green, renewable technology.